| Ms Taina L Connelly, MS | |
|
110 Jfk Dr Ste 118, Atlantis, FL 33462-1146 | |
| (561) 812-2000 | |
| Not Available |
| Full Name | Ms Taina L Connelly |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 110 Jfk Dr Ste 118, Atlantis, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104957356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 52668 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | 4168 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Taina L Connelly, MS 110 Jfk Dr Ste 118, Atlantis, FL 33462-1146 Ph: (561) 812-2000 | Ms Taina L Connelly, MS 110 Jfk Dr Ste 118, Atlantis, FL 33462-1146 Ph: (561) 812-2000 |
News Archive
Star Scientific, Inc. announced that on Friday, June 18 the company filed an application with the Food & Drug Administration for approval to market Stonewall-BDL™ as a "modified risk tobacco product" under the Family Smoking Prevention and Tobacco Control Act of 2009. This is Star's second such application to the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
The number of connections between nerve cells in the brain can be regulated by an immune system molecule, according to a new study from UC Davis. The research, published Feb. 27 in the journal Nature Neuroscience, reveals a potential link between immunity, infectious disease and conditions such as schizophrenia or autism.
Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a paucity of guidance for effectively providing care and minimizing pain.
Tony Trenkle, the federal official responsible for Healthcare.gov's launch and security, is moving to the private sector. CBS News reports that Trenkle was supposed to sign off on the site's security before launch but didn't.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 2 days ago